Study directory

Depression studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
6115studies shown
Showing 997-1,008 of 6,115
Drug study icon
TerminatedNCT04821271

Antidepressant Effects of TS-161 in Treatment-Resistant Depression

This summary needs review. Please check the official study record and contact the research team for details.

In Bethesda
Why is this study shown?

This study is directly about Depression.

DepressionDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
United States
Sponsor
National Institute of Mental Health (NIMH)
Condition
Depression
Device study icon
Active Not RecruitingNCT02046330

Deep Brain Stimulation (DBS) Therapy for Treatment Resistant Depression

This summary needs review. Please check the official study record and contact the research team for details.

In Houston
Why is this study shown?

This study is directly about Depression.

DepressionDeviceA study involving a tool, app, wearable, test, or medical device.From 22 Years to 70 Years
Countries
United States
Sponsor
The University of Texas Health Science Center, Houston
Condition
Depression
Drug study icon
UnknownNCT05809609

Glutamate Emotion Memory Study

This summary needs review. Please check the official study record and contact the research team for details.

In Oxford
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 20 Years to 60 Years
Countries
United Kingdom
Sponsor
University of Oxford
Condition
Depression
Device study icon
CompletedNCT06165445

Optimizing tDCS Protocol for Clinical Use in Major Depressive Disorder

This summary needs review. Please check the official study record and contact the research team for details.

In Zanjan
Why is this study shown?

This study is directly about Depression.

DepressionDeviceFrom 18 Years to 60 Years
Countries
Iran
Sponsor
The National Brain Mapping Laboratory (NBML)
Condition
Depression
Device study icon
UnknownNCT06350396

pBFS-guided rTMS Over DMPFC for Treatment-Resistant Depression

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Hebei
Why is this study shown?

This study is directly about Depression.

DepressionDeviceFrom 18 Years to 65 Years
Countries
China
Sponsor
Changping Laboratory
Condition
Depression
Drug study icon
CompletedNCT06230757

Psilocybin for Treatment-Resistant Depression

This summary needs review. Please check the official study record and contact the research team for details.

In Aurora
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 21 Years to 75 Years
Countries
United States
Sponsor
University of Colorado, Denver
Condition
Depression
Drug study icon
CompletedEUCTR 2018-002782-19

A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF CARIPRAZINE AS AN ADJUNCT TO ANTIDEPRESSANTS IN THE TREATMENT OF PATIENTS WITH MAJOR DEPRESSIVE DISORDER WHO HAVE HAD AN INADEQUATE RESPONSE TO ANTIDEPRE...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

Multiple locations, including Phoenix
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 65 Years
Countries
United States, United Kingdom, Bulgaria, ...
Sponsor
Allergan Ltd.
Condition
Depression
Drug study icon
Not recruitingISRCTN31103960

MSP-1014.OX for depression

This study is not recruiting in the United Kingdom. OX for depression.

In United Kingdom
Why is this study shown?

This study is directly about Depression.

DepressionOtherOver 18 Years
Countries
United Kingdom
Sponsor
Clerkenwell Health
Condition
Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.